Last10K.com

American Bio Medica Corp (ABMC) SEC Filing 10-K Annual report for the fiscal year ending Sunday, December 31, 2017

American Bio Medica Corp

HISTORY TOOLS
CIK: 896747 Ticker: ABMC
Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2017
Apr. 11, 2018
Jun. 30, 2017
Document And Entity Information [Abstract]   
Document Type10-K  
Amendment Flagfalse  
Document Period End DateDec. 31, 2017  
Document Fiscal Year Focus2017  
Document Fiscal Period FocusFY  
Entity Registrant NameAMERICAN BIO MEDICA CORP  
Entity Central Index Key0000896747  
Current Fiscal Year End Date--12-31  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Current Reporting StatusYes  
Entity Filer CategorySmaller Reporting Company  
Entity Public Float  $ 1,781,000
Trading SymbolABMC  
Entity Common Stock, Shares Outstanding 29,932,770 

View differences made from one year to another to evaluate American Bio Medica Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Bio Medica Corp.

Continue

Assess how American Bio Medica Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Bio Medica Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Balance Sheets
Balance Sheets (parenthetical)
Statement Of Operations
Statements Of Cash Flow
Statements Of Changes In Stockholders' Equity
Accrued Expenses And Other Current Liabilities
Accrued Expenses And Other Current Liabilities (details)
Accrued Expenses And Other Current Liabilities (tables)
Commitments, Contingencies And Other Matters
Commitments, Contingencies And Other Matters (details Narrative)
Commitments, Contingencies And Other Matters (details)
Commitments, Contingencies And Other Matters (tables)
Debt And Line Of Credit
Debt And Line Of Credit (details 1)
Debt And Line Of Credit (details)
Debt And Line Of Credit (tables)
Income Taxes
Income Taxes (details 1)
Income Taxes (details Narrative)
Income Taxes (details)
Income Taxes (tables)
Inventory
Inventory (details)
Inventory (tables)
Other Income / Expense
Property, Plant And Equipment
Property, Plant And Equipment (details Narrative)
Property, Plant And Equipment (details)
Property, Plant And Equipment (tables)
Related Party Note Payable
Segment And Geographic Information
Segment And Geographic Information (details)
Segment And Geographic Information (tables)
Stockholders' Equity
Stockholders' Equity (details 1)
Stockholders' Equity (details 2)
Stockholders' Equity (details 3)
Stockholders' Equity (details Narrative)
Stockholders' Equity (details)
Stockholders' Equity (tables)
Subsequent Event
The Company And Its Significant Accounting Policies
The Company And Its Significant Accounting Policies (details Narrative)
The Company And Its Significant Accounting Policies (details)
The Company And Its Significant Accounting Policies (policies)
The Company And Its Significant Accounting Policies (tables)
Ticker: ABMC
CIK: 896747
Form Type: 10-K Annual Report
Accession Number: 0001654954-18-003884
Submitted to the SEC: Thu Apr 12 2018 5:25:01 PM EST
Accepted by the SEC: Thu Apr 12 2018
Period: Sunday, December 31, 2017
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/abmc/0001654954-18-003884.htm